HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relation of Vasoplegia in the Absence of Primary Graft Dysfunction to Mortality Following Cardiac Transplantation.

Abstract
Vasoplegia following cardiac transplantation is associated with increased morbidity and mortality. Previous studies have not accounted for primary graft dysfunction (PGD). The definition of vasoplegia is based on pressor requirement at 48 hours, many PGD parameters may have normalized after the initial 24 hours on inotropes. We surmised that the purported negative effects of vasoplegia following transplantation may in part be driven by PGD. We reviewed 240 consecutive adult cardiac transplants at our center between 2012 and 2016. The severity of vasoplegia was evaluated as a risk factor for 1-year survival, and the analysis was repeated for the subgroup of 177 patients who did not develop PGD. Overall, 63 (26%) of patients developed mild, moderate, or severe PGD. In those without PGD, vasoplegia was associated with length of stay but not with short- or long-term mortality. Moderate and/or severe vasoplegia occurred in 35 (15%) patients and was associated with higher short-term mortality, length of stay, and PGD. Multivariate logistic regression identified body mass index ≥35 kg/m2, left ventricular assist device before transplantation, and use of extracorporeal membrane oxygenation as joint risk factors for vasoplegia. In patients without PGD, only left ventricular assist device before transplantation was associated with vasoplegia. In conclusion, our results show that, in the sizeable subgroup of patients with no signs of PGD, vasoplegia had a much more modest impact on post-transplant morbidity and no significant effect on 1- and 3-year survival. This suggests that PGD may be a confounder when assessing vasoplegia as a risk factor for adverse outcomes.
AuthorsFayez S Raza, Andy Y Lee, Aayla K Jamil, Huanying Qin, Joost Felius, Aldo E Rafael, Gonzalo V Gonzalez-Stawinski, Shelley A Hall, Susan M Joseph, Brian Lima, Amarinder S Bindra
JournalThe American journal of cardiology (Am J Cardiol) Vol. 122 Issue 11 Pg. 1902-1908 (12 01 2018) ISSN: 1879-1913 [Electronic] United States
PMID30442225 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018. Published by Elsevier Inc.
Topics
  • Aged
  • Female
  • Follow-Up Studies
  • Heart Transplantation (adverse effects, mortality)
  • Hospital Mortality (trends)
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications (epidemiology, etiology)
  • Primary Graft Dysfunction
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Survival Rate (trends)
  • Texas (epidemiology)
  • Vasoplegia (etiology, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: